ACET
Price
$3.41
Change
-$0.17 (-4.75%)
Updated
Oct 30, 04:52 PM (EDT)
Capitalization
33.51M
5 days until earnings call
Intraday BUY SELL Signals
IMTX
Price
$7.20
Change
-$0.11 (-1.50%)
Updated
Oct 30, 04:59 PM (EDT)
Capitalization
1.11B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACET vs IMTX

ACET vs IMTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACET vs. IMTX commentary
Oct 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and IMTX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACET with price predictions
Oct 29, 2026

ACET's RSI Indicator stays in oversold zone for 16 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +12.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACET advanced for three days, in 239 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

ACET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

ACET moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACET crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

The 50-day moving average for ACET moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for ACET entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.279) is normal, around the industry mean (3.070). P/E Ratio (-0.344) is within average values for comparable stocks, (-1.257). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.491) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.237).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for IMTX with price predictions
Oct 29, 2026

IMTX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 02, 2026

IMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 46 cases where IMTX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMTX's RSI Oscillator exited the oversold zone, 27 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on IMTX as a result. In 70 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for IMTX just turned positive on October 21, 2026. Looking at past instances where IMTX's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.

Following a +2.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMTX advanced for three days, in 220 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 60 of 65 cases where IMTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for IMTX entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.785) is normal, around the industry mean (3.070). P/E Ratio (-4.597) is within average values for comparable stocks, (-1.257). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.491) among similar stocks. P/S Ratio (23.202) is also within normal values, averaging (439.237).

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. IMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
ACET vs IMTX: Fundamental Ratings
ACET
IMTX
OUTLOOK RATING
1..100
5131
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9379
P/E GROWTH RATING
1..100
822
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (32) in the null industry is in the same range as ACET (47) in the Medical Distributors industry. This means that IMTX’s stock grew similarly to ACET’s over the last 12 months.

IMTX's Profit vs Risk Rating (100) in the null industry is in the same range as ACET (100) in the Medical Distributors industry. This means that IMTX’s stock grew similarly to ACET’s over the last 12 months.

IMTX's SMR Rating (98) in the null industry is in the same range as ACET (98) in the Medical Distributors industry. This means that IMTX’s stock grew similarly to ACET’s over the last 12 months.

IMTX's Price Growth Rating (79) in the null industry is in the same range as ACET (93) in the Medical Distributors industry. This means that IMTX’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (8) in the Medical Distributors industry is in the same range as IMTX (22) in the null industry. This means that ACET’s stock grew similarly to IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETIMTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend about 1 month ago
84%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
COMPARISON
Comparison
Oct 31, 2026
Stock price -- (ACET: $3.58 vs. IMTX: $7.31)
Brand notoriety: ACET and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 99% vs. IMTX: 125%
Market capitalization -- ACET: $33.51M vs. IMTX: $1.11B
ACET [@Biotechnology] is valued at $33.51M. IMTX’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $136.87B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green while IMTX’s FA Score has 2 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 2 green, 3 red.
According to our system of comparison, both ACET and IMTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • IMTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -16.36% price change this week, while IMTX (@Biotechnology) price change was -3.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.39%. For the same industry, the average monthly price growth was -11.11%, and the average quarterly price growth was -14.21%.

Reported Earning Dates

ACET is expected to report earnings on Nov 04, 2026.

IMTX is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (+5.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACET
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-6.04%
VIR - ACET
44%
Loosely correlated
-1.51%
OGI - ACET
41%
Loosely correlated
+0.54%
RXRX - ACET
40%
Loosely correlated
-2.53%
ABEO - ACET
38%
Loosely correlated
+0.22%
IMTX - ACET
37%
Loosely correlated
-0.54%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with SLDB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-0.54%
SLDB - IMTX
53%
Loosely correlated
-1.39%
TSHA - IMTX
48%
Loosely correlated
-0.24%
ABEO - IMTX
47%
Loosely correlated
+0.22%
VIR - IMTX
47%
Loosely correlated
-1.51%
DNTH - IMTX
46%
Loosely correlated
+0.47%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.610.21
+6.18%
Psyence Biomedical Ltd.
BZUN3.360.07
+2.13%
Baozun
TTWO193.39-1.90
-0.97%
Take-Two Interactive Software
FLOC20.05-0.30
-1.47%
Flowco Holdings Inc
EWTX38.91-1.58
-3.90%
Edgewise Therapeutics